2m 2m 2m 2m 2m 2m 2m
Heron Therapeuti (HRTX)
NASDAQ
$0.35-$0.003 (-0.81%)
Price as of Oct 02, 2026 6:41 PM EDT- $67.6MMarket Cap
- -72.62%1-Year Change
- BiotechnologyIndustry
Heron Therapeuti (HRTX)
$0.35-$0.003 (-0.81%)
HRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.36 | ||
Change | +$0.04 (+13.52%) | ||
Open | $0.32 | ||
High | $0.36 | ||
Low | $0.31 | ||
Previous Close | $0.31 | ||
Volume | 3,182,114 | ||
30-Day Average Volume | 2,206,518 | ||
1-Week Change | 22.72% | ||
1-Month Change | 12.98% | ||
1-Year Change | -72.62% | ||
3-Year Change | -65.45% | ||
5-Year Change | -96.71% | ||
Fundamentals | |||
Shares Outstanding | 189.9M | ||
Total Assets | $252.3M | ||
Market Cap | $67.6M | ||
Enterprise Value | $80.8M | ||
Period: QTR TTM FY | |||
Revenue | $37.7M | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$2.4M | ||
EBIT | -$2.3M | ||
EBITDA | -$1.8M | ||
Net Working Capital | $137.7M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -44 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 10 | ||
P/E | -12 | ||
PEG | -0 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue